ALFRED JONCZYK,CHRISTIANE AMENDT,DIETER DORSCH,FRANK ZENKE,GUENTER HOELZEMANN
申请号：
BR112013022948
公开号：
BR112013022948A2
申请日:
2012.02.13
申请国别(地区):
BR
年份:
2016
代理人:
摘要：
The present invention relates to novel pyrido[2,3-b]pyrazine compounds of formula (I): and to the use of such compounds in which the inhibition, regulation and/or modulation of signal transduction by ATP consuming proteins like kinases plays a role, particularly to inhibitors of TGF-beta receptor kinases, and to the use of such compounds for the treatment of kinase-induced diseases, in particular for the treatment of tumors.
